| Literature DB >> 34325644 |
Ikechukwu Ifedili1, Kristina Mouksian2, David Jones2, Ibrahim El Masri1, Mark Heckle1, John Jefferies1, Yehoshua C Levine1.
Abstract
Atrial Fibrillation (AF) is the most common form of electrical disturbance of the heart and contributes to significant patient morbidity and mortality. With a better understanding of the mechanisms of atrial fibrillation and improvements in mapping and ablation technologies, ablation has become a preferred therapy for patients with symptomatic AF. Pulmonary Vein Isolation (PVI) is the cornerstone for AF ablation therapy, but particularly in patients with AF occurring for longer than 7 days (persistent AF), identifying clinically significant nonpulmonary vein targets and achieving durability of ablation lesions remains an important challenge. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.Entities:
Keywords: Atrial fibrillation; ablation; cryoballoon; left atrium; pulmonary vein isolation; radiofrequency
Mesh:
Year: 2022 PMID: 34325644 PMCID: PMC9413731 DOI: 10.2174/1573403X17666210729101752
Source DB: PubMed Journal: Curr Cardiol Rev ISSN: 1573-403X